Memorandum from a Who/Ish Meeting

References

• Mac Mahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774
   PubMed Web of Science ®Google Scholar
• Evans JG, Rose G. Hypertension. Br Med Bull 1971; 27: 37–42
   PubMed Web of Science ®Google Scholar
• Kannel WB. Hypertension and the risk of cardiovascular disease. Hypertension: Pathophysiology, Diagnosis, and Management, JH Laragh, BM Brenner. Raven Press, New York 1990; 101–117
   Google Scholar
• Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349–1354
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255–3264
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281–1285
   PubMed Web of Science ®Google Scholar
• MRC Working Party. Medical Research Council trial on treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405–412
   PubMed Web of Science ®Google Scholar
• MRC Working Party. Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Br Med J 1988; 296: 1565–1570
   PubMed Web of Science ®Google Scholar
• MRC Working Party on Mild to Moderate Hypertension: The MRC Mild Hypertension trial: some subgroup results. Mild Hypertension: From Drug Trials to Practice, T Strasser, D Ganten. Raven Press, New York 1987; 9–20
   Google Scholar
• Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987; 9: 209–215
   PubMed Web of Science ®Google Scholar
• Julius S, Jamerson K, Gudbrandsson T, Schork N. White coat hypertension: a follow-up. Clin Exper Hypertens 1992; A14: 45–53
   Google Scholar
• Mancia G. Ambulatory blood pressure monitoring: research and clinical applications. J Hypertens 1990; 8(suppl 7)S1–S13
   Google Scholar
• O'Brien E, Petrie J, Littler W, et al. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens 1990; 8: 607–619
   PubMed Web of Science ®Google Scholar
• Sega R, Cesana GC, Pagani R, et al (1993) Ambulatory and home blood pressure normality: the PAMELA Study. Abstr 6th Meeting on Hypertension; Milan. 1993, 694
   Google Scholar
• Chatellier G, Battaglia C, Pagny J-Y, Plouin P-F, Ménard J. Decision to treat mild hypertension after assessment by ambulatory monitoring and World Health Organization recommendations. Br Med J 1992; 305: 1062–1066
   PubMed Web of Science ®Google Scholar
• Zanchetti A. What blood pressure level should be treated?. Hypertension: Pathophysiology, Diagnosis, and Management, JH Laragh, BM Brenner. Raven Press, New York 1990; 1967–1983
   Google Scholar
• Rose GA. Hypertension in the community. Epidemiology of Hypertension, Handbook of Hypertension, CJ Bulpitt. Elsevier Science Publishers, Amsterdam 1985
   Google Scholar
• Report by the Management Committee. The Australian Therapeutic Trial in Mild Hypertension: untreated mild hypertension. Lancet 1982; 1: 185–191
   PubMedGoogle Scholar
• Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97–104
   PubMed Web of Science ®Google Scholar
• Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838
   PubMed Web of Science ®Google Scholar
• WHO/ISH Guidelines Committee. Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Clin Exper Hypertens 1992; A14: 333–341
   Google Scholar
• Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension: the Framingham study. Circulation 1986; 61: 1179–1182
   Google Scholar
• Joffres MR, Hamet P, Rabkin SW, Geskey SW, Hogan K. Fodor G for the Canadian Heart Health Surveys Research Group: Prevalence, control and awareness of high blood pressure among Canadian adults. Can Med Ass J 1992; 146: 1997–2005
   PubMed Web of Science ®Google Scholar
• Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Int Med 1993; 153: 154–183
   PubMed Web of Science ®Google Scholar
• WHO Expert Committee. Arterial Hypertension. World Health Organization, Geneva 1978
   Google Scholar
• Zanchetti A. Goals of antihypertensive treatment: prevention of cardiovascular events and prevention of organ damage. Blood Pressure 1992; 1: 205–211
   PubMedGoogle Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566
   PubMed Web of Science ®Google Scholar
• Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352
   PubMed Web of Science ®Google Scholar
• Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Hypertension 1989; 13(suppl 1)80–93
   Google Scholar
• Ruilope LM. Proteinuria and renal function. High Blood Press 1993; 2(suppl 1)50–53
   Google Scholar
• Parving H-M, Hommel E. Prognosis in diabetic nephropathy. Br Med J 1989; 299: 230–233
   PubMed Web of Science ®Google Scholar
• Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987; 1: 581–584
   PubMed Web of Science ®Google Scholar
• The HOT Study Group. The Hypertension Optimal Treatment Study (The HOT-Study). Blood Pressure 1993; 2: 62–68
   PubMedGoogle Scholar
• Langford HG, Stamler J, Wassertheil-Smoller S, Prineas RJ. All-cause mortality in the Hypertension Detection and Follow-up Program: findings in the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Progr Cardiovasc Dis 1986; 29(suppl 1)29–54
   PubMedGoogle Scholar
• Mancia G, Groppelli A, Casadei R, Omboni S, Mutti E, Parati G. Cardiovascular effects of smoking. Clin Exper Hypertens 1990; A12: 917–929
   Google Scholar
• Layde PM, Beral V, Kay CR. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet 1981; 1: 541–546
   PubMed Web of Science ®Google Scholar
• Wren BG, Routledge DA. Blood pressure changes: oestrogens in climateric women. Med J Aust 1981; 2: 528–531
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Sleight P, Birkenhäger WH. Evaluation of organ damage in hypertension. Consensus document. High Blood Pressure 1993; 2(Suppl 1)92–104
   Google Scholar
• Lithell H. Insulin resistance and cardiovascular drugs. Clin Exper Hypertens 1992; A14: 151–162
   Google Scholar
• Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction. An overview of the randomized trials. Progr Cardiovasc Dis 1985; 27: 335–371
   PubMed Web of Science ®Google Scholar
• Kreft-Jais C, Plouin P-F, Tchobroutsky C. Angiotensin converting enzyme inhibition with captopril in human pregnancy. J Hypertens 1987; 5: S553–S554
   Google Scholar
• The solvd Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293–301
   PubMed Web of Science ®Google Scholar
• The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 685–691
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E, Moy L, et al. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992; 327: 669–677
   PubMed Web of Science ®Google Scholar
• Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992; 340: 1173–1178
   PubMed Web of Science ®Google Scholar
• Zanchetti A. The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. Clin Exper Hypertens 1992; A14: 307–331
   Google Scholar
• Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the Second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991; 67: 1295–1297
   PubMed Web of Science ®Google Scholar
• Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E. for the SPRINT Study Group: Early administration of nifedipine in suspected acute myocardial infarction. Arch Intern Med 1993; 153: 345–353
   PubMed Web of Science ®Google Scholar
• Reid JL, Elliott HL. Clinical Pharmacology of Antihypertensive Drugs. Handbook of Hypertension, Doyle AE. Elsevier Science Publishers, Amsterdam 1984; 92–112
   Google Scholar
• Dahlöf B, Hansson L, Ekbom T, et al. STOP-hypertension 2. Abstr. 6th Europ Meet Hypertens. 1993; 4–7
   Google Scholar
• Amery A, Birkenhäger W, Bulpitt CJ. Syst-Eur. 5 A multicenter trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol and organization. Aging 1991; 3: 287–302
   PubMedGoogle Scholar